×
About 560 results

ALLMedicine™ Paroxysmal Supraventricular Tachycardia Center

Research & Reviews  103 results

Circulating microRNA‑423 attenuates the phosphorylation of calcium handling proteins in...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985206
Molecular Medicine Reports; Park H, Park H et. al.

Mar 30th, 2022 - MicroRNAs (miRNAs) are small non‑coding RNAs that control patterns of gene expression by inducing the degradation of mRNAs. In addition, miRNAs are known to serve an important role in the pathogenesis of atrial fibrillation (AF). In general, AF is...

TROPONIN TESTING IN ADULT PATIENTS PRESENTING TO THE EMERGENCY DEPARTMENT FOR PAROXYSMA...
https://doi.org/10.1097/CRD.0000000000000444
Cardiology in Review; Gabrielli M, Cucurachi R et. al.

Feb 12th, 2022 - International guidelines define as paroxysmal supraventricular tachycardia (PSVT) all supraventricular tachyarrhythmias other than atrial flutter and atrial fibrillation. Associate symptoms, such as chest pain and dyspnea, and possible ECG changes...

Comparing methods of adenosine administration in paroxysmal supraventricular tachycardi...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790832
BMC Cardiovascular Disorders; Daengbubpha P, Wittayachamnankul B et. al.

Jan 28th, 2022 - Intravenous adenosine is the recommended treatment for paroxysmal supraventricular tachycardia (PSVT). There is no official recommended method of giving adenosine. We compared the success rates between a standard and alternative method of first do...

Outcomes of supraventricular tachycardia ablation: Results from the Singapore ablation ...
https://doi.org/10.1111/pace.14410
Pacing and Clinical Electrophysiology : PACE; Tan ESJ, Chan SP et. al.

Nov 19th, 2021 - The Singapore Cardiac Databank was designed to monitor the performance and outcomes of catheter ablation. We investigated the outcomes of paroxysmal supraventricular tachycardia (PSVT)-ablation in a prospective, nationwide, cohort study. Atriovent...

Frequency of Cardiac Arrhythmias in Children with Cardiological Consulting and Containi...
https://doi.org/10.2174/1871529X21666210914113115
Cardiovascular & Hematological Disorders Drug Targets; Nezami A, Heidari G et. al.

Sep 16th, 2021 - Heart diseases are the leading causes of mortality and Congenital Heart Disease (CHD) is the most common birth defect reported worldwide. The aim of this study was to evaluate the incidence of arrhythmias and CHD and the association between the tw...

see more →

Drugs  105 results see all →

Clinicaltrials.gov  4 results

Efficacy and Safety of Intranasal MSP-2017 (Etripamil) for the Conversion of PSVT to Sinus Rhythm
https://clinicaltrials.gov/ct2/show/NCT02296190

Dec 30th, 2020 - This is a multi-center, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the effects of 4 different doses of MSP-2017 (Etripamil) in subjects with paroxysmal supraventricular tachycardia. It includes an up to 21-day Scr...

Study on Left Atrial Function of Paroxysmal Supraventricular Tachycardia After Radiofrequency Ablation
https://clinicaltrials.gov/ct2/show/NCT03348436

Mar 18th, 2020 - A total of 100 patients with persistent,in whom successful RF ablation of slow pathway or accessory pathway was performed. Patients with atrial fibrillation, structural heart disease, ventricular arrhythmias, impaired left ventricular systolic fu...

Pemetrexed as Second-Line Therapy in Treating Patients With Hormone Refractory Prostate Cancer
https://clinicaltrials.gov/ct2/show/NCT00216099

Jul 29th, 2016 - OUTLINE: This is a multi-center study. Pemetrexed 500mg/m2 will be administered intravenously over approximately 10-minutes on Day 1 of a 21-day cycle. Folic Acid (350-1000 mcg. PO daily) will be taken by patients to reduce toxicity. At least 5 da...

Cisplatin, Gemcitabine and Bevacizumab in Combination for Metastatic Transitional Cell Cancer
https://clinicaltrials.gov/ct2/show/NCT00234494

Mar 14th, 2016 - OUTLINE: This is a multi-center study. Cisplatin 70 mg/m2 Day 1 Gemcitabine 1250 mg/m2 Day 1 and 8 Bevacizumab 15 mg/kg Day 1 Review toxicity every cycle (every 3 weeks) Review for radiographic response every 2 cycles (every six weeks) Progressive...

see more →

News  11 results

Nasal Spray for Converting Paroxysmal SVT Seems Feasible, Safe for Long-term Use
https://www.medscape.com/viewarticle/973808

May 11th, 2022 - A nasal spray that delivers a short-acting calcium-channel blocker (CCB), envisioned as a self-treatment alternative to a pill-in-the-pocket strategy for managing bouts of paroxysmal supraventricular tachycardia (PSVT), has advanced another step i...

Nasal Spray Resurrected After Showing Clinical Benefits for PSVT
https://www.medscape.com/viewarticle/951243

May 16th, 2021 - Significant improvement in the control of symptoms related to paroxysmal supraventricular tachycardia (PSVT) is resurrecting etripamil as a self-administered nasal spray a year after it failed to meet the primary endpoint in a phase 3 trial, accor...

13 weeks' gestation • heart palpitations • chest tightness • Dx?
https://www.mdedge.com/node/171019/path_term/51948
The Journal of Family Practice; Joseph Lane Wilson, MD, Bridgid Hast Wilson, MD, PhD et. al.

Aug 1st, 2018 - THE CASE A 29-year-old G1P0 woman at 13 weeks’ gestation came in for a routine prenatal visit complaining of sudden-onset heart palpitations that were occurring about once a week. Each episode lasted between 15 and 60 minutes and was accompanied b.

Nasal-Spray Calcium-Channel Blocker Promising for Converting Paroxysmal SVT
https://www.medscape.com/viewarticle/899738

Jul 24th, 2018 - Self-treatment of acute paroxysmal supraventricular tachycardia (SVT) with a nasal spray containing a short-acting calcium-channel blocker is likely to be possible with a high rate of conversion to sinus rhythm, suggests a phase 2 study. The nasal...

NODE-1: Simple Nasal Spray May Short-circuit Acute PSVT
https://www.medscape.com/viewarticle/880046

May 16th, 2017 - CHICAGO, IL — A nasal spray containing the calcium-channel blocker etripamil could allow patients to convert acute paroxysmal supraventricular tachycardia (PSVT) outside the hospital, phase 2 data from the Intranasal Etripamil for the Conversion o...

see more →

Patient Education  1 results see all →